Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Rectal Neoplasms 7Oropharyngeal Neoplasms 7Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 3Lung Neoplasms 3Hypopharyngeal Neoplasms 3Glioblastoma 3Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Radiation Injuries 2Pathologic Complete Response 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Laryngeal Neoplasms 2Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Thymoma 1Smoking Cessation 1Smoking 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1Resectable Esophageal Cancer 1Rectal Malignant Neoplasms 1Postoperative Complications 1

Interventions

Gemcitabine 56pembrolizumab 50Cisplatin 43Magnetic Resonance Spectroscopy 27enfortumab vedotin 22Specimen Handling 22Nivolumab 22Cystectomy 18durvalumab 16Carboplatin 16avelumab 15Mitomycin 14atezolizumab 13Docetaxel 13Cystoscopy 12Fluorouracil 11Radiation 9Transurethral Resection of Bladder 8Radiotherapy 8Ipilimumab 8sacituzumab govitecan 7Standard of Care 7Radiosurgery 7Paclitaxel 7Immunoglobulin G 7Disulfides 7erdafitinib 6cemiplimab 6Surveys and Questionnaires 6Surgical Procedures, Operative 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Chemoradiotherapy × 1 year × Clear all
NCT07008833 2026-02-12

REDEMPTED

Brazilian Clinical Research Institute

Phase NA Not yet recruiting
336 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡